A significant difference was observed between OS and disease-free survival (DFS) of patients with breast cancer (n=1746), which indicates that the patients with CCND1 alternations has improved prognosis as compared with those without CCND1 alternations. The gene discussed is CCND1; the disease is breast carcinoma.